-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 17, the Jiangsu Provincial Market Supervision Bureau and the Food and Drug Administration jointly issued the Notice on Further Strengthening the Work of Ensuring the Supply and Stabilizing the Price of Medical Supplies, the full text of which is as follows:
Circular on further strengthening the work of ensuring the supply and price of medical supplies
In order to implement the relevant decision-making and deployment of the provincial party committee and the provincial government, adhere to ensuring supply, quality and price, and further stabilize and standardize the order of the medical supplies market, the relevant matters related to strengthening market supervision and ensuring supply and price stability are hereby notified as follows:
First, pharmaceutical retail enterprises should adhere to the overall situation and people's livelihood as the foundation, increase supply, ensure normal operation, and must not arbitrarily suspend business and suspend business, and must not stock up on goods and sell
them.
them.
2.
Pharmaceutical retail enterprises should strictly implement the system of clearly marked prices, and must not take the opportunity of the epidemic to significantly increase the prices of medical supplies, and must not fabricate and disseminate information on price increases, hoard and bid up prices
.
Pharmaceutical retail enterprises should strictly implement the system of clearly marked prices, and must not take the opportunity of the epidemic to significantly increase the prices of medical supplies, and must not fabricate and disseminate information on price increases, hoard and bid up prices
.
3.
Pharmaceutical retail enterprises shall strictly abide by the laws and regulations on drug management and the quality management practices for drug sales, and shall not sell counterfeit drugs or unqualified drugs
such as expired and invalid.
Pharmaceutical retail enterprises shall strictly abide by the laws and regulations on drug management and the quality management practices for drug sales, and shall not sell counterfeit drugs or unqualified drugs
such as expired and invalid.
4.
Pharmaceutical retail enterprises shall operate in good faith, and must not carry out acts of unfair competition such as false publicity, counterfeiting and confusion, and must not bundle sales
.
Pharmaceutical retail enterprises shall operate in good faith, and must not carry out acts of unfair competition such as false publicity, counterfeiting and confusion, and must not bundle sales
.
5.
Licensed pharmacists of pharmaceutical retail enterprises should guide the public to purchase and dispense drugs scientifically and rationally according to actual needs, do not rush or stock up on drugs, and provide the public with suggestions on diversified drug options
.
Licensed pharmacists of pharmaceutical retail enterprises should guide the public to purchase and dispense drugs scientifically and rationally according to actual needs, do not rush or stock up on drugs, and provide the public with suggestions on diversified drug options
.
All sectors of society and the general public are welcome to actively participate in supervision and report problems
through 12315 and other channels of complaint and reporting.
The market supervision and drug regulatory departments will seriously investigate and deal with illegal acts such as selling counterfeit drugs, expired and ineffective drugs, taking the lead in price increases, colluding in price increases, or raising prices in disguised form, and transfer suspected crimes to the public security organs for investigation of criminal responsibility
in accordance with law.
through 12315 and other channels of complaint and reporting.
The market supervision and drug regulatory departments will seriously investigate and deal with illegal acts such as selling counterfeit drugs, expired and ineffective drugs, taking the lead in price increases, colluding in price increases, or raising prices in disguised form, and transfer suspected crimes to the public security organs for investigation of criminal responsibility
in accordance with law.
Jiangsu Provincial Administration for Market Regulation Jiangsu Provincial Drug Administration
December 17, 2022
